MODIGRAF 0,2 mg Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

modigraf 0,2 mg

astellas ireland co. ltd. - irlanda - tacrolimusum - gran. pt. susp. orala - 0,2 mg - imunosupresoare inhibitori de calcineurina

PROTOPIC 0,03% Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

protopic 0,03%

astellas ireland co. ltd. - irlanda - tacrolimusum - unguent - 0,03% - alte preparate de uz dermatologic alte preparate de uz dermatologic

PROTOPIC 0,1% Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

protopic 0,1%

astellas ireland co. ltd. - irlanda - tacrolimusum - unguent - 0,1% - alte preparate de uz dermatologic alte preparate de uz dermatologic

PRYLAR 2,5 mg/5 mg Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

prylar 2,5 mg/5 mg

adamed pharma s.a. - polonia - combinatii (ramiprilum + amlodipinum) - caps. - 2,5mg/5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu

PRYLAR 5 mg/5 mg Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

prylar 5 mg/5 mg

adamed pharma s.a. - polonia - combinatii (ramiprilum + amlodipinum) - caps. - 5mg/5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu

PRYLAR 10 mg/5 mg Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

prylar 10 mg/5 mg

adamed pharma s.a. - polonia - combinatii (ramiprilum + amlodipinum) - caps. - 10mg/5mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu

PRYLAR 5 mg/10 mg Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

prylar 5 mg/10 mg

adamed pharma s.a. - polonia - combinatii (ramiprilum + amlodipinum) - caps. - 5mg/10mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu

PRYLAR 10 mg/10 mg Romania - Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

prylar 10 mg/10 mg

adamed pharma s.a. - polonia - combinatii (ramiprilum + amlodipinum) - caps. - 10mg/10mg - combinatii de inhibitori a.c.e. inhibitori ai e.c.a. si blocante ale canalelor de calciu

Wencon 150 150 mg capsule Moldova - Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

wencon 150 150 mg capsule

zim laboratories limited - fluconazolum - capsule - 150 mg

Xtandi Kesatuan Eropah - Romania - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostate neoplasme - terapia endocrină - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.